Marc L. de Somer
Nessuna posizione attualmente
Profilo
Marc L.
de Somer formerly worked at Galderma International SAS, as Executive Director, Alkermes, Inc., as Vice President-Clinical Research & Development, Cita NeuroPharmaceuticals, Inc., as Executive Vice President-Research & Development, Cervelo Pharmaceuticals Ltd., as Chief Medical Officer, EVP-Research & Development in 2009, Voyager Therapeutics, Inc., as Vice President-Clinical Research & Development, Relmada Therapeutics, Inc., as Senior Vice President-Clinical Development from 2020 to 2022, and PPD, Inc., as Vice President-Neurology.
Dr. de Somer received his graduate degree and Masters Business Admin degree from Harvard University, doctorate degree from Université Libre de Bruxelles, doctorate degree from Instituut voor Tropische Geneeskunde, and Masters Business Admin degree from Columbia Business School.
Precedenti posizioni note di Marc L. de Somer
| Società | Posizione | Fine |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2022 |
Cervelo Pharmaceuticals Ltd.
 Cervelo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cervelo Pharmaceuticals Ltd. engages in the preparation of pharmaceuticals. It develops drug product candidates for neuropathic, inflammatory, and neurodegenerative diseases. The company was founded by Anthony J. Giovinazzo in 2006 and is headquartered in Mississauga, Canada. | Direttore Tecnico/Scientifico/R&S | 15/12/2009 |
Cita NeuroPharmaceuticals, Inc.
 Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Direttore Tecnico/Scientifico/R&S | - |
| PPD, INC. | Corporate Officer/Principal | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Formazione di Marc L. de Somer
| Université Libre de Bruxelles | Doctorate Degree |
| Harvard University | Graduate Degree |
| Instituut voor Tropische Geneeskunde | Doctorate Degree |
| Columbia Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Cervelo Pharmaceuticals Ltd.
Cervelo Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cervelo Pharmaceuticals Ltd. engages in the preparation of pharmaceuticals. It develops drug product candidates for neuropathic, inflammatory, and neurodegenerative diseases. The company was founded by Anthony J. Giovinazzo in 2006 and is headquartered in Mississauga, Canada. | Health Technology |
Cita NeuroPharmaceuticals, Inc.
Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Health Technology |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
- Borsa valori
- Insiders
- Marc L. de Somer